Adagene Stock Number Of Employees

ADAG Stock  USD 1.75  0.07  3.85%   
Adagene fundamentals help investors to digest information that contributes to Adagene's financial success or failures. It also enables traders to predict the movement of Adagene Stock. The fundamental analysis module provides a way to measure Adagene's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Adagene stock.
Short Long Term Debt TotalTotal Assets2.3M2.6M8.0M7.5M28.0M22.3M25.7M12.9M54.4M105.9M84.3M189.5M152.4M115.7M133.1M128.7M100%
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Adagene Company Number Of Employees Analysis

Adagene's Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.

Number of Employees

 = 

Full Time

+

Part Time

More About Number Of Employees | All Equity Analysis

Current Adagene Number Of Employees

    
  174  
Most of Adagene's fundamental indicators, such as Number Of Employees, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Adagene is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Adagene Number Of Employees Driver Correlations

Understanding the fundamental principles of building solid financial models for Adagene is extremely important. It helps to project a fair market value of Adagene Stock properly, considering its historical fundamentals such as Number Of Employees. Since Adagene's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Adagene's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Adagene's interrelated accounts and indicators.
0.890.880.6-0.98-0.830.910.39-0.470.890.691.00.880.970.690.880.640.65
0.891.00.49-0.8-0.840.870.36-0.811.00.680.890.920.830.680.920.890.72
0.881.00.46-0.78-0.860.880.32-0.811.00.690.880.930.820.690.930.890.75
0.60.490.46-0.59-0.470.570.19-0.240.50.680.60.50.480.670.50.330.35
-0.98-0.8-0.78-0.590.76-0.85-0.430.33-0.8-0.61-0.98-0.8-0.97-0.61-0.8-0.51-0.54
-0.83-0.84-0.86-0.470.76-0.960.110.58-0.88-0.9-0.83-0.95-0.71-0.9-0.95-0.68-0.94
0.910.870.880.57-0.85-0.960.08-0.580.90.890.910.970.80.890.970.730.83
0.390.360.320.19-0.430.110.08-0.270.29-0.260.390.130.52-0.270.130.32-0.37
-0.47-0.81-0.81-0.240.330.58-0.58-0.27-0.8-0.49-0.48-0.72-0.39-0.49-0.72-0.95-0.52
0.891.01.00.5-0.8-0.880.90.29-0.80.740.890.940.820.740.940.880.77
0.690.680.690.68-0.61-0.90.89-0.26-0.490.740.690.850.51.00.850.60.88
1.00.890.880.6-0.98-0.830.910.39-0.480.890.690.880.970.690.880.650.65
0.880.920.930.5-0.8-0.950.970.13-0.720.940.850.880.780.851.00.830.83
0.970.830.820.48-0.97-0.710.80.52-0.390.820.50.970.780.50.780.560.51
0.690.680.690.67-0.61-0.90.89-0.27-0.490.741.00.690.850.50.850.60.88
0.880.920.930.5-0.8-0.950.970.13-0.720.940.850.881.00.780.850.830.83
0.640.890.890.33-0.51-0.680.730.32-0.950.880.60.650.830.560.60.830.58
0.650.720.750.35-0.54-0.940.83-0.37-0.520.770.880.650.830.510.880.830.58
Click cells to compare fundamentals
Employee typically refers to an individual working under a contract of employment, whether oral or written, express or implied, and has recognized his or her rights and duties. Most officers of corporations are included as employees and contractors are generally excluded.
Competition

Based on the recorded statements, Adagene is currently employing 174 people. This is 98.42% lower than that of the Biotechnology sector and 67.5% lower than that of the Health Care industry. The number of employees for all United States stocks is 99.08% higher than that of the company.

Adagene Number Of Employees Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Adagene's direct or indirect competition against its Number Of Employees to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Adagene could also be used in its relative valuation, which is a method of valuing Adagene by comparing valuation metrics of similar companies.
174.00158.00136.0081.00100%
Adagene is currently under evaluation in number of employees category among its peers.

Adagene Fundamentals

Return On Equity-0.46
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-350%-300%-250%-200%-150%-100%-50%
Return On Asset-0.2
Operating Margin(45.35) %
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-50%0%50%100%150%200%250%
Current Valuation5.69 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-100%-80%-60%-40%-20%
Shares Outstanding44.27 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-3110%20%30%40%
Shares Owned By Insiders10.65 %
Shares Owned By Institutions25.54 %
Number Of Shares Shorted40.12 K
Price To Book1.42 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-100%-80%-60%-40%-20%
Price To Sales98.77 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-100%0%100%200%300%
Revenue18.11 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-310%500%1,000%
Gross Profit10.18 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-310%500%1,000%
EBITDA(14.95 M)
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-310%100%200%300%400%
Net Income(18.95 M)
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31100%200%300%400%
Cash And Equivalents168.04 M
Cash Per Share3.87 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-3150%100%150%200%
Total Debt22.31 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31200%400%600%800%1,000%
Debt To Equity0.15 %
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-700%-600%-500%-400%-300%-200%-100%0%
Current Ratio3.10 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-50%0%50%100%150%
Book Value Per Share1.28 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-400%-300%-200%-100%0%100%
Cash Flow From Operations(28.45 M)
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-3150%100%150%200%250%
Short Ratio0.33 X
Earnings Per Share(0.72) X
Target Price10.54
Number Of Employees174
Beta0.58
Market Capitalization108.46 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-80%-60%-40%-20%0%
Total Asset115.73 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-3150%100%150%200%250%
Retained Earnings(277.75 M)
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31100%200%300%400%500%
Working Capital81.99 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31
Net Asset115.73 M

About Adagene Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Adagene's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Adagene using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Adagene based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

When determining whether Adagene is a strong investment it is important to analyze Adagene's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Adagene's future performance. For an informed investment choice regarding Adagene Stock, refer to the following important reports:
Check out Adagene Piotroski F Score and Adagene Altman Z Score analysis.
For more detail on how to invest in Adagene Stock please use our How to Invest in Adagene guide.
You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Adagene. If investors know Adagene will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Adagene listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.72)
Revenue Per Share
0.019
Quarterly Revenue Growth
(0.85)
Return On Assets
(0.20)
Return On Equity
(0.46)
The market value of Adagene is measured differently than its book value, which is the value of Adagene that is recorded on the company's balance sheet. Investors also form their own opinion of Adagene's value that differs from its market value or its book value, called intrinsic value, which is Adagene's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Adagene's market value can be influenced by many factors that don't directly affect Adagene's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Adagene's value and its price as these two are different measures arrived at by different means. Investors typically determine if Adagene is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Adagene's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.